APH(APH)
APH
Q4 2026 EPS Estimate
$1.42
Oct 28, 2026 · Reports before open
Revenue Estimate
$9.35B
FY2026E EPS$5.27
FY2027E EPS$6.43
Analyst Sentiment
Wall St. Consensus
Buy26 analysts·High coverage
64
Score
16 Buy (62%)9 Hold (35%)1 Sell (3%)
Rating Breakdown
Strong Buy
00%
Buy
1662%
Hold
935%
Sell
14%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$165.00
-1.3%
Consensus
$198.50
+18.8%
Bull
$215.00
+28.7%
12-Month Target Range26 analysts
$165.00$198.50$215.00
Current $167.11Consensus
Current Price
$167.11
Upside to Consensus
$31.39
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+17.68%
EPS+21.98%
FY2028
Rev+12.17%
EPS+12.96%
FY2029
Rev+7.44%
EPS+17.10%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $35.27B | $41.50B | $46.55B | $50.02B |
| Low | $34.49B | $39.24B | $42.14B | $47.10B |
| High | $36.13B | $42.73B | $49.27B | $52.19B |
| EBITDA Avg | $8.84B | $10.41B | $11.67B | $12.54B |
| Low | $8.65B | $9.84B | $10.57B | $11.81B |
| High | $9.06B | $10.72B | $12.35B | $13.09B |
| EBIT Avg | $7.59B | $8.93B | $10.02B | $10.77B |
| Low | $7.43B | $8.45B | $9.07B | $10.14B |
| High | $7.78B | $9.20B | $10.61B | $11.23B |
| Net Income Avg | $6.71B | $8.41B | $9.69B | $10.87B |
| Low | $6.55B | $7.88B | $7.51B | $10.04B |
| High | $6.86B | $8.72B | $10.70B | $11.48B |
| EPS Avg | $5.27 | $6.43 | $7.26 | $8.51 |
| Low | $5.13 | $6.17 | $5.88 | $7.86 |
| High | $5.37 | $6.82 | $8.38 | $8.99 |
| Analysts (Rev / EPS) | 11 / 8 | 11 / 10 | 9 / 5 | 4 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $9.35B | $9.59B | $9.35B | $10.22B | $10.64B | $10.79B | $10.68B | $11.51B |
| Low | $9.30B | $9.31B | $9.01B | $9.86B | $10.26B | $10.41B | $10.30B | $11.10B |
| High | $9.41B | $9.89B | $9.67B | $10.58B | $11.01B | $11.17B | $11.05B | $11.91B |
| EBITDA Avg | $2.34B | $2.41B | $2.34B | $2.56B | $2.67B | $2.71B | $2.68B | $2.89B |
| Low | $2.33B | $2.33B | $2.26B | $2.47B | $2.57B | $2.61B | $2.58B | $2.78B |
| High | $2.36B | $2.48B | $2.43B | $2.65B | $2.76B | $2.80B | $2.77B | $2.99B |
| EBIT Avg | $2.01B | $2.07B | $2.01B | $2.20B | $2.29B | $2.32B | $2.30B | $2.48B |
| Low | $2.00B | $2.00B | $1.94B | $2.12B | $2.21B | $2.24B | $2.22B | $2.39B |
| High | $2.03B | $2.13B | $2.08B | $2.28B | $2.37B | $2.40B | $2.38B | $2.56B |
| Net Income Avg | $1.83B | $1.88B | $1.79B | $2.05B | $2.17B | $2.20B | $2.05B | $2.36B |
| Low | $1.77B | $1.81B | $1.71B | $1.96B | $2.07B | $2.10B | $1.96B | $2.25B |
| High | $1.86B | $1.94B | $1.87B | $2.14B | $2.26B | $2.30B | $2.14B | $2.46B |
| EPS Avg | $1.42 | $1.46 | $1.39 | $1.59 | $1.68 | $1.71 | $1.59 | $1.83 |
| Low | $1.37 | $1.41 | $1.33 | $1.52 | $1.60 | $1.63 | $1.52 | $1.74 |
| High | $1.44 | $1.51 | $1.45 | $1.66 | $1.76 | $1.79 | $1.66 | $1.91 |
| Analysts (Rev / EPS) | 8 / 9 | 8 / 8 | 4 / 3 | 5 / 4 | 4 / 3 | 5 / 4 | 3 / 4 | 4 / 5 |